Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis
- Conditions
- Rheumatoid ArthritisCardiovascular DiseasesAtherosclerosis, Coronary
- Registration Number
- NCT03813017
- Lead Sponsor
- Ziv Hospital
- Brief Summary
Cardiovascular disease is a leading cause for morbidity and mortality in general population. The incidence of cardiovascular disease and their poor outcome is well documented in a broad spectrum of connective tissue diseases, especially in rheumatoid arthritis (RA). The risk of incident CVD is increased by 48% in patients with RA compared to the general population.
RA is associated with 50% increase in the mortality in patients with cardiovascular disease (CVD). One reason is the more frequent cardiovascular risk factors in RA patients compared with the general population. Patients with RA have a high risk of premature cardiovascular disease (CVD). The aim of the present study is to assess whether there are non-invasive measures that might predict arteriosclerosis in RA patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
-
18-70 years old (except for women till 75 years old)
-
Absence of established CVD:
- Myocardial Infarction p/h
- PCI with balloon and/or stent
- Intermittent claudication
- PAD / intervention
- CAS /intervention
-
Signed informed consent form
-
Documented diagnosis of rheumatoid arthritis
- Known CVD
- Pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular disease risks in patient with theumatoid arthritis 6 months Prediction of cardiovascular risks and proposed preventive treatment
- Secondary Outcome Measures
Name Time Method